267 related articles for article (PubMed ID: 18757324)
1. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS;
J Clin Oncol; 2008 Sep; 26(25):4109-15. PubMed ID: 18757324
[TBL] [Abstract][Full Text] [Related]
2. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy.
Ding PQ; Batra A; Xu Y; McKinnon GP; Cheung WY
Clin Colorectal Cancer; 2020 Sep; 19(3):209-218. PubMed ID: 32291245
[TBL] [Abstract][Full Text] [Related]
3. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
Sinicrope FA; Foster NR; Yothers G; Benson A; Seitz JF; Labianca R; Goldberg RM; Degramont A; O'Connell MJ; Sargent DJ;
Cancer; 2013 Apr; 119(8):1528-36. PubMed ID: 23310947
[TBL] [Abstract][Full Text] [Related]
4. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
[TBL] [Abstract][Full Text] [Related]
5. Obesity is an independent prognostic variable in colon cancer survivors.
Sinicrope FA; Foster NR; Sargent DJ; O'Connell MJ; Rankin C
Clin Cancer Res; 2010 Mar; 16(6):1884-93. PubMed ID: 20215553
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer.
Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N
J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987
[TBL] [Abstract][Full Text] [Related]
7. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Heseltine D; Niedzwiecki D; Hollis D; Saltz LB; Mayer RJ; Thomas J; Nelson H; Whittom R; Hantel A; Schilsky RL; Fuchs CS
J Clin Oncol; 2006 Aug; 24(22):3535-41. PubMed ID: 16822843
[TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
[TBL] [Abstract][Full Text] [Related]
9. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Meyerhardt JA; Catalano PJ; Haller DG; Mayer RJ; Benson AB; Macdonald JS; Fuchs CS
Cancer; 2003 Aug; 98(3):484-95. PubMed ID: 12879464
[TBL] [Abstract][Full Text] [Related]
10. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer.
Alipour S; Kennecke HF; Woods R; Lim HJ; Speers C; Brown CJ; Gill S; Renouf DJ; Cheung WY
J Gastrointest Cancer; 2013 Jun; 44(2):203-10. PubMed ID: 23264206
[TBL] [Abstract][Full Text] [Related]
12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
13. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
Van Blarigan EL; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Ng K; Meyerhardt JA
JAMA Oncol; 2018 Jun; 4(6):783-790. PubMed ID: 29710284
[TBL] [Abstract][Full Text] [Related]
14. Body mass index and body weight change during adjuvant chemotherapy in colon cancer patients: results from the AVANT trial.
Lee DW; Cho S; Shin A; Han SW; Kim TY
Sci Rep; 2020 Nov; 10(1):19467. PubMed ID: 33173165
[TBL] [Abstract][Full Text] [Related]
15. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
16. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
[TBL] [Abstract][Full Text] [Related]
17. Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Program analysis.
Dasenbrock HH; Liu KX; Chavakula V; Devine CA; Gormley WB; Claus EB; Smith TR; Dunn IF
J Neurosurg; 2017 Mar; 126(3):677-689. PubMed ID: 27203139
[TBL] [Abstract][Full Text] [Related]
18. Impact of Chemotherapy Dosing on Ovarian Cancer Survival According to Body Mass Index.
Bandera EV; Lee VS; Rodriguez-Rodriguez L; Powell CB; Kushi LH
JAMA Oncol; 2015 Sep; 1(6):737-45. PubMed ID: 26181758
[TBL] [Abstract][Full Text] [Related]
19. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS
J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087
[TBL] [Abstract][Full Text] [Related]
20. Prognostic influence of body mass index and body weight gain during adjuvant FOLFOX chemotherapy in Korean colorectal cancer patients.
Lee DW; Han SW; Cha Y; Lee KH; Kim TY; Oh DY; Im SA; Bang YJ; Park JW; Ryoo SB; Jeong SY; Kang GH; Park KJ; Kim TY
BMC Cancer; 2015 Oct; 15():690. PubMed ID: 26467912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]